Skip to main content
Premium Trial:

Request an Annual Quote

Judy Lieberman

Premium

Alnylam Pharmaceuticals has named Judy Lieberman, a senior investigator at the CBR Institute for Biomedical Research and a professor at Harvard Medical School, to its scientific advisory board.

The appointment comes a little more than a month after Alnylam licensed delivery technology developed by Lieberman from Harvard.

Lieberman holds a PhD in physics from Rockefeller University and an MD from the joint Harvard-Massachusetts Institute of Technology program in health, science, and technology.

The Scan

Pig Organ Transplants Considered

The Wall Street Journal reports that the US Food and Drug Administration may soon allow clinical trials that involve transplanting pig organs into humans.

'Poo-Bank' Proposal

Harvard Medical School researchers suggest people should bank stool samples when they are young to transplant when they later develop age-related diseases.

Spurred to Develop Again

New Scientist reports that researchers may have uncovered why about 60 percent of in vitro fertilization embryos stop developing.

Science Papers Examine Breast Milk Cell Populations, Cerebral Cortex Cellular Diversity, Micronesia Population History

In Science this week: unique cell populations found within breast milk, 100 transcriptionally distinct cell populations uncovered in the cerebral cortex, and more.